| Application no. and date | 21169137.3 (espacenet) (Federated) (European Patent Register), 20040409 | | Patent/reg. no. and date | DK/EP 3889142, 20220615 | | Publication date | 20211006 | | Priority no. and date | US 461988 P, 20030411 | | EP pub. no. and date |
EP 3889142 20211006 | | Effective date | | | Applicant/owner | PTC Therapeutics, Inc., 100 Corporate Court, Middlesex Business Center
South Plainfield, NJ 07080, US | | Applicant ref. no. | 1639533 | | Inventor | Karp, Gary, Mitchell,
Princeton Junction, 08550, US,
Hwang, Seongwoo,
Edison, 08817, US,
Chen, Guangming,
Bridgewater, 08807, US,
Almstead, Neil G.,
Princeton, 08540, US,
Moon, Young-Choon,
Belle Mead, 08502, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/4245 (2006.01) , A61P 35/00 (2006.01) , C07D 271/06 (2006.01) | | Title | 1,2,4-OXADIAZOLBENZOESYREFORBINDELSER OG DERES ANVENDELSE TIL NONSENSE-SUPPRESSION OG BEHANDLING AF SYGDOM | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
